Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Ecotoxicology
2006 Nov 01;158:647-56. doi: 10.1007/s10646-006-0102-4.
Show Gene links
Show Anatomy links
A toxicity and hazard assessment of fourteen pharmaceuticals to Xenopus laevis larvae.
Richards SM
,
Cole SE
.
???displayArticle.abstract???
The toxicity of fourteen widely used human pharmaceuticals was determined using the Frog Embryo Teratogenesis Assay-Xenopus (FETAX). Stage 9 Xenopus blastulae were exposed for 96 h to single concentrations of commonly prescribed selective serotonin reuptake inhibitors (SSRIs), statin blood lipid regulators, non-steroidal anti-inflammatories, antibiotics, a stimulant, and an anti-epileptic. Toxicity, teratogenicity, minimum concentration to inhibit growth, and types and severity of associated malformations were determined. EC(10)s ranged from 3.0 mg/l to >100 mg/l and LC(10)s ranged from 3.6 mg/l to >100 mg/l. Toxicity varied between and within compound class of pharmaceutical. The fluoroquinolones, stimulants, anti-epileptics, and antibiotics tested were determined to be nontoxic and non-teratogenic at singular, water-soluble concentrations. The hazard quotients (HQ) for the pharmaceuticals ranged from 6.10 x 10(-7 )to 1.6 x 10(-4), all of which are orders of magnitude below EPA's levels for concern for harm to aquatic animals. Thus, based on the data from the present study, concentrations of individual pharmaceuticals currently detected in surface water are far below concentrations of effective and lethal concentrations.
Arkhipova,
[Presynaptic effects of arachidonic acid and prostaglandin E2 in the frog neuromuscular synapse].
2005, Pubmed
Arkhipova,
[Presynaptic effects of arachidonic acid and prostaglandin E2 in the frog neuromuscular synapse].
2005,
Pubmed
Ashton,
Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom.
2004,
Pubmed
Boyd,
Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada.
2003,
Pubmed
Cahill,
Determination of pharmaceutical compounds in surface- and ground-water samples by solid-phase extraction and high-performance liquid chromatography-electrospray ionization mass spectrometry.
2004,
Pubmed
Chen,
Molecular mechanisms of fluoroquinolone resistance.
2003,
Pubmed
Daughton,
Pharmaceuticals and personal care products in the environment: agents of subtle change?
1999,
Pubmed
Els,
Dual role of prostaglandins (PGE2) in regulation of channel density and open probability of epithelial Na+ channels in frog skin (R. pipiens).
1997,
Pubmed
Fabro,
The relative teratogenic index and teratogenic potency: proposed components of developmental toxicity risk assessment.
1982,
Pubmed
Farré,
Determination of drugs in surface water and wastewater samples by liquid chromatography-mass spectrometry: methods and preliminary results including toxicity studies with Vibrio fischeri.
2001,
Pubmed
Fong,
Putative serotonin reuptake inhibitor-induced spawning and parturition in freshwater bivalves is inhibited by mammalian 5-HT2 receptor antagonists.
2003,
Pubmed
Fort,
Evaluation of the developmental toxicity of caffeine and caffeine metabolites using the frog embryo teratogenesis assay--Xenopus (FETAX).
1998,
Pubmed
,
Xenbase
Fort,
Evaluation of the developmental toxicity of five compounds with the frog embryo teratogenesis assay: Xenopus (FETAX) and a metabolic activation system.
1989,
Pubmed
,
Xenbase
Fraker,
Direct and interactive effects of ecologically relevant concentrations of organic wastewater contaminants on Rana pipiens tadpoles.
2004,
Pubmed
Goodnick,
Selective serotonin reuptake inhibitors in affective disorders--I. Basic pharmacology.
1998,
Pubmed
Hirsch,
Occurrence of antibiotics in the aquatic environment.
1999,
Pubmed
Huber,
Serotonin and aggressive motivation in crustaceans: altering the decision to retreat.
1997,
Pubmed
Johnson,
Exposure assessment and microcosm fate of selected selective serotonin reuptake inhibitors.
2005,
Pubmed
Kolpin,
Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance.
2002,
Pubmed
Lien,
Morphological abnormalities in African catfish (Clarias gariepinus) larvae exposed to malathion.
1997,
Pubmed
Lin,
Inhibition and induction of cytochrome P450 and the clinical implications.
1998,
Pubmed
McLean,
Carbamazepine and 10,11-epoxycarbamazepine produce use- and voltage-dependent limitation of rapidly firing action potentials of mouse central neurons in cell culture.
1986,
Pubmed
Metcalfe,
Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada.
2003,
Pubmed
Miao,
Determination of pharmaceuticals in aqueous samples using positive and negative voltage switching microbore liquid chromatography/electrospray ionization tandem mass spectrometry.
2003,
Pubmed
Minsker,
Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase.
1983,
Pubmed
Richards,
Biochemical effects of chlorpyrifos on two developmental stages of Xenopus laevis.
2002,
Pubmed
,
Xenbase
Richards,
Physical effects of chlorpyrifos on two stages of xenopus laevis.
2003,
Pubmed
,
Xenbase
Sakamoto,
Developmental toxicity of caffeine in the larvae of Xenopus laevis.
1993,
Pubmed
,
Xenbase
Schloss,
The serotonin transporter: a primary target for antidepressant drugs.
1998,
Pubmed
Schooley,
Edema associated with ibuprofen therapy.
1977,
Pubmed
Shuey,
Serotonin as a regulator of craniofacial morphogenesis: site specific malformations following exposure to serotonin uptake inhibitors.
1992,
Pubmed
Smith,
Effects of three organic wastewater contaminants on American toad, Bufo americanus, tadpoles.
2005,
Pubmed
Stumpf,
Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil.
1999,
Pubmed
Teraoka,
Muscular contractions in the zebrafish embryo are necessary to reveal thiuram-induced notochord distortions.
2006,
Pubmed
Thomas,
The occurrence of selected human pharmaceutical compounds in UK estuaries.
2004,
Pubmed
von Keutz,
Preclinical safety evaluation of cerivastatin, a novel HMG-CoA reductase inhibitor.
1998,
Pubmed
Zuehlke,
Determination of polar drug residues in sewage and surface water applying liquid chromatography-tandem mass spectrometry.
2004,
Pubmed
